D-003 does not possess oestrogenic potential in-vivo: Findings of the uterotrophic assay

Journal of Pharmacy and Pharmacology

Volumn 59, Issue 10, 2007, Pages 1433-1437

  Noa, Miriam ^a   Mendoza, Sarahí ^a   Mas, Rosa ^a   Gámez, Rafael ^a   Valle, Maikel ^a   Pardo, Balia ^a   Gutiérrez, Ariadne ^a   Mendoza, Nilda ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

D 003; ESTRADIOL BENZOATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VOLUME; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ENDOMETRIUM; EPITHELIUM CELL; ESTROGEN ACTIVITY; FEMALE; IN VIVO STUDY; NONHUMAN; OVARIECTOMY; RAT; TREATMENT DURATION; TREATMENT PLANNING; UTERUS WEIGHT;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; ENDOMETRIUM; EPITHELIAL CELLS; ESTRADIOL; FATTY ACIDS; FEMALE; ORGAN SIZE; OVARIECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

EID: 35348999125     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.59.10.0015     Document Type: Article

References (32)

1. Bahl, S., Coates, P. S. Greenspan S. L. (2003) The management of osteoporosis following hip fracture: have we improved our care? Osteoporos. Int. 14: 884-888
2. Castaño, G., Mas, R., Fernández, L., Lopez, E., Gutierrez, J. A., Illnait, J., Fernandez, J. C., Gamez, R., Alvarez, E. (2002) Assessment of the effects of D-003, a new antiplatelet and lipid-lowering compound, in healthy volunteers. Drugs RD 3: 337-348
3. Castaño, G., Mas, R., Fernández, L., Illnait, J., Lopez. E., Gamez, R., Mendoza, S., Fernandez, J., Mesa, M. (2003a) Effects of D-003 on lipid profile of patients with type II hypercholesterolemia: a phase II clinical study. Clin. Drug Invest. 23: 789-802
4. Castaño, G., Menéndez, R., Mas, R., Ledón, N, Fernández, J. C., Pérez, J., González, R. M. (2003b) Effects of D-003 on lipid profile and lipid peroxidation in healthy volunteers. Clin. Drug Invest. 23: 193-203
5. Ceballos, A., Mas, R., Castaño, G., Fernández, L., Mendoza, S., Menéndez, R., González, J. J., Illnait, J., Gámez, R., Mesa, M., Fernández, L. (2005) The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study. Int. J. Clin. Pharmacol. Res. 25: 175-186
6. Cuddihy, M. T., Gabriel, S. E., Crowson, C. S., Atkinson, E. J., Tabini, C., O'Fallon, W. M., Melton, L. J. (2002) Osteoporosis intervention following distal forearm fractures: a missed opportunity? Arch. Intern. Med. 162: 421-426
7. Gámez, R., Mendoza, S., Mas, R., Mesa, R., Castaño, G., Marrero, D. (2000) Dose-dependent cholesterol-lowering effects of D-003 on normocholesterolemic rabbits. Curr. Ther. Res. Clin. Exp. 61: 8-16
8. Josse, R. G. (1996) Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women. J. Can. Med. Assoc. 155: 929-937.
9. Kanno, J., Onyon, L., Haseman, J., Fenner-Crisp, P., Ashby, J. (2001) The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: Phase 1. J. Environ. Health Perspect. 109: 785-794
10. Kanno, J., Onyon, L., Peddada, S., Ashby, J., Jacob, E., Owens, W. (2003) The OECD program to validate the rat uterotrophic bioassay. Phase 2. J. Environ. Health Perspect. 111: 1530-1549
11. Looker, A. C., Johnston, C. C., Wahner, H. W., Dunn, W. L., Calvo, M. S., Harris, T. B., Heyse, S. P., Lindsay, R. L. (1995) Prevalence of low femoral bone density in older US women from NHANES III. J. Bone Miner. Res. 10: 796-802
12. Luckman, S. P., Hughes, D. E., Coxon, F. P., Grahan, R., Russell, G., Rogers, M. J. (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J. Bone Miner. Res. 13: 581-589
13. Manolagas, S. (2000) Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21: 115-137
14. Más, R. (2004) D-003: A new substance with promising lipid modifying and pleiotropic effects for atherosclerosis management. Drugs Future 29: 773-786
15. Méndez, E., Marrero, D., González, V., Laguna, A. (2003) GC determination of long chain fatty acids that compose D003 in 5-mg film-coated tablets. J. Pharm. Biomed. Anal. 31: 613-620
16. Méndez, E., Marrero, D., González, V., Tejeda, Y., Sierra, R., Cora, M. (2004) Validation of a gas chromatographic method for determining fatty acids that compose D-003 in 10 mg film-coated tablets. Farmaco 59: 543-547
17. Mendoza, S., Gamez, R., Mas, R., Goicochea, E. (2003) Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits. Int. J. Tissue React. 25: 81-90
18. -1), a mixture of high molecular weight aliphatic acids from sugarcane wax, on bones and bone cell apoptosis in ovariectomized rats. Int. J. Tissue React. 27: 213-222
19. Mendoza, S., Noa, M., Mas, R. (2005b) A comparison of the effects of D-003, a mixture of high molecular weight aliphatic acids from sugarcane wax, and pravastatin, on bones and osteoclast apoptosis of ovariectomized rats. Drugs Exp. Clin. Res. 31: 181-191
20. Menéndez, R., Más, R., Amor, A. M., Rodeiro, I., González, R. M., Alfonso, J. L. (2001) Inhibition of cholesterol biosynthesis in cultured fibroblasts by D-003, a mixture of very long chain saturated fatty acids. Pharmacol. Res. 44: 299-304
21. Menéndez, R., Mas, R., Pérez, Y., Ledón, N., Pérez, J., González, R. M., Rodeiro. I., Zayas, M. Jiménez, S. (2002) Inhibition of rat lipoprotein lipid peroxidation by the oral administration of D-003, a mixture of very long chain saturated fatty acids. Can. J. Physiol. Pharmacol. 80: 13-17
22. Menéndez, R., Más, R., Pérez, J., González, R. M., Jiménez, S. (2003) Oral administration of D-003, a mixture of very long chain saturated fatty acids, prevents casein-induced endogenous hypercholesterolemia in rabbits. Can. J. Physiol. Pharmacol. 82: 22-29
23. Noa, M., Más, R., Mendoza, S., Gámez, R., Mendoza, N. (2004a) Effects of D-003, a mixture of high molecular weight aliphatic acids from sugar cane wax, on bones from ovariectomized rats. Drugs Exp. Clin. Res. 30: 35-41
24. Noa, M., Mendoza, S., Más, R., Mendoza, N., León, F. (2004b) Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague Dawley rats. Drugs RD 5: 281-290
25. Parhami, F., Morrow, A., Balucan, J., Tintut, Y. (1997) Lipid oxidation products have opposite effect on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb. Vasc. Biol. 17: 680-687
26. Seeman, E., Delmas, P. D. (2006) Bone quality. The material and structural basis of bone strength and fragility. N Engl J. Med. 354: 2250-2261
27. Staal, A., Frith, J. C., French, M., Swartz, J., Gungor, T. (2003) The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J. Bone Miner. Res. 18: 88-96
28. Tinwell, H., Soames, A. R., Foster, J., Ashby, J. (2000) Rat uterotrophic assays. J. Environ. Health Perspect. 108: 631-634
29. Toniolo, P., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K., Pasternack, B. (1995) A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J. Natl Cancer Inst. 87: 190-197
30. Watts, N. (1997) Osteoporosis: prevention, detection and treatment. J. Med. Assoc. Ga 86(3): 224-226
31. Weinstein, R., Manolagas, S. (2000) Apoptosis and osteoporosis. Am. J. Med. 108: 153-164
32. Xu, H., Watkins, B., Seifert, M. (1995) Vitamin E stimulates trabecular bone formation and alters epiphyseal cartilage morphometry. Calcif. Tissue Int. 57: 293-300